Results 21 to 30 of about 96,936 (279)

NONMUSCLE INVASIVE TRANSITIONAL CELL CARCINOMA OF URINARY BLADDER – ADJUVANT INTRAVESICAL THERAPIES AFTER TRANSURETHRAL TUMOR RESECTION [PDF]

open access: yesRomanian Medical Journal, 2017
Introduction. More than 70% of all bladder cancers are nonmuscle invasive involving only the mucosa and the submucosa. A large percentage of patients present local recurrence after endoscopic surgery, and many of them progress to muscle invasive disease ...
Nicolae Grigore   +3 more
doaj   +1 more source

The effect of birth weight and gestational age on BCG-induced immune responses in infants following BCG vaccination [PDF]

open access: yes, 2010
Includes bibliographical references (leaves 102-114).Bacillus Calmette?Gu?rin (BCG), the only currently licensed tuberculosis (TB) vaccine, provides variable efficacy. Despite the use of BCG, TB remains a global health problem.
Dube, Frederick
core   +1 more source

Serendipity and strategy in rapid innovation

open access: yesNature Communications, 2017
Organizations can take different approaches to innovation: they can either follow a strategic process or a serendipitous perspective. Here Fink et al. develop a statistical model to analyse how components combine to obtain a product and thus explain the ...
T. M. A. Fink   +3 more
doaj   +1 more source

Intravescical instillation of Calmette-Guérin bacillus and COVID-19 risk

open access: yesHuman Vaccines & Immunotherapeutics, 2021
It has been theorized that Calmette-Guérin bacillus may prevent or reduce the severity of COVID-19 through a nonspecific stimulation of the immune system. A preliminary assessment of SARS-CoV-2 infection rates and outcomes among 2803 individuals affected
Ugo Fedeli   +6 more
doaj   +1 more source

A unique case of miliary pulmonary tuberculosis induced by bacillus Calmette-Guérin intravesical instillation with COVID-19 superinfection

open access: yesSouth African Journal of Radiology, 2021
Intravesical instillation of Bacillus Calmette-Guérin (BCG) is used as an adjuvant treatment of bladder cancer. Systemic BCG infection occurs in less than 1% of cases, and pulmonary involvement is even rarer (0.3% – 0.7%), with a favourable prognosis.
Nicolò Brandi   +3 more
doaj   +1 more source

Open Multi-dose Vaccine Vials: Use or Discard? [PDF]

open access: yesPediatric Infectious Disease, 2022
Multi-dose vials are useful and economical when large numbers of patients need to be immunized. These multi-dose vials are invaluable in the National Immunization Programme vaccination days, as they save time and effort and also are economically viable ...
Sumitha Nayak
doaj   +1 more source

Boosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: Different boosting intervals and implications for efficacy trials [PDF]

open access: yes, 2007
Objectives. To investigate the safety and immunogenicity of boosting BCG with modified vaccinia Ankara expressing antigen 85A (MVA85A), shortly after BCG vaccination, and to compare this first with the immunogenicity of BCG vaccination alone and second
Whelan, KT   +35 more
core   +1 more source

The Effect of Stress, BCG Vaccination,and Combination of Stress-BCG Vaccination to The Ability of Macrophage to Bind with CD4+ T Cells in BALB/c Mice [PDF]

open access: yes, 2006
The Effect of Stress, BCG Vaccination,and Combination of Stress-BCG Vaccination to The Ability of Macrophage to Bind with CD4+ T Cells in BALB/c Mice Rahajeng N. Tunjung*, Dwi Pudjonarko** Background.
Tunjung, Rahajeng_N.
core   +1 more source

The staging of re-TURB is crucial in predicting the response to BCG therapy in patients with T1 high-grade bladder cancer [PDF]

open access: yesInvestigative and Clinical Urology
Purpose: This study aimed to evaluate whether the pathological findings from repeat transurethral resection of bladder (re-TURB) predict Bacillus Calmette–Guérin (BCG) response in patients with T1 high-grade bladder cancer.
Hyomyoung Lee   +7 more
doaj   +1 more source

Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany

open access: yesHuman Vaccines & Immunotherapeutics, 2021
Bacillus Calmette-Guérin (BCG) vaccine is known to have “bystander benefits” in protecting against heterologous infections; interim analysis of the “ACTIVATE” trial shows protection against respiratory infections in the elderly population.
Daniela Marín-Hernández   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy